Effects of downhill walking in pulmonary rehabilitation for patients with COPD: a randomised controlled trial.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
09 2020
Historique:
received: 16 09 2019
accepted: 26 04 2020
pubmed: 24 5 2020
medline: 22 6 2021
entrez: 24 5 2020
Statut: epublish

Résumé

The development of contractile muscle fatigue (CMF) affects training responses in patients with chronic obstructive pulmonary disease (COPD). Downhill walking induces CMF with lower dyspnoea and fatigue than level walking. This study compared the effect of pulmonary rehabilitation (PR) comprising downhill walking training (DT) to PR comprising level walking (conventional training (CT)) in patients with COPD.In this randomised controlled trial, 35 patients (62±8 years; forced expiratory volume in 1 s (FEV

Identifiants

pubmed: 32444407
pii: 13993003.00639-2020
doi: 10.1183/13993003.00639-2020
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02113748']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©ERS 2020.

Déclaration de conflit d'intérêts

Conflict of interest: C.A. Camillo has nothing to disclose. Conflict of interest: C.R. Osadnik has nothing to disclose. Conflict of interest: C. Burtin has nothing to disclose. Conflict of interest: S. Everaerts has nothing to disclose. Conflict of interest: M. Hornikx has nothing to disclose. Conflict of interest: H. Demeyer has nothing to disclose. Conflict of interest: M. Loeckx has nothing to disclose. Conflict of interest: F.M. Rodrigues has nothing to disclose. Conflict of interest: K. Maes has nothing to disclose. Conflict of interest: G. Gayan-Ramirez has nothing to disclose. Conflict of interest: W. Janssens reports grants and personal fees from Boehringer Ingelheim, AstraZeneca, GSK and Chiesi, outside the submitted work; and is senior clinical researcher of FWO co-founder of ArtiQ. Conflict of interest: T. Troosters has nothing to disclose.

Auteurs

Carlos Augusto Camillo (CA)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
University Pitágoras UNOPAR, Department of Rehabilitation Sciences, Londrina, Brazil.
Both authors contributed equally.

Christian Robert Osadnik (CR)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
Monash University, Department of Physiotherapy, Victoria, Australia.
Monash Health, Monash Lung and Sleep, Victoria, Australia.
Both authors contributed equally.

Chris Burtin (C)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
Hasselt University, REVAL Rehabilitation Research Center, BIOMED Biomedical Research Institute, Faculty of Rehabilitation Sciences, Belgium.

Stephanie Everaerts (S)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
University Hospital Leuven, Respiratory Division and Rehabilitation, Leuven, Belgium.

Miek Hornikx (M)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
University Hospital Leuven, Respiratory Division and Rehabilitation, Leuven, Belgium.

Heleen Demeyer (H)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium.

Matthias Loeckx (M)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
Department of Physiotherapy, LUNEX International University of Health, Exercise and Sports, Differdange, Luxembourg.

Fernanda Machado Rodrigues (FM)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.

Karen Maes (K)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.

Ghislaine Gayan-Ramirez (G)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.

Wim Janssens (W)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
University Hospital Leuven, Respiratory Division and Rehabilitation, Leuven, Belgium.

Thierry Troosters (T)

Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium thierry.troosters@kuleuven.be.
University Hospital Leuven, Respiratory Division and Rehabilitation, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH